Globus Medical price target lowered to $61 from $67 at Wells Fargo

Wells Fargo analyst Vik Chopra lowered the firm’s price target on Globus Medical to $61 from $67 and keeps an Equal Weight rating on the shares. The firm notes the company reported Q4 results that were below its estimates on the top line, but ahead on EPS.